Elements of Th1/Th2 response and disease severity in COVID‐19 patients: A short report
The presence of a complex immune dysregulation syndrome has been established in COVID‐19 patients. We aimed to assess Th1/Th2 response in COVID‐19 patients and its association with disease severity by performing a prospective cohort study in a tertiary hospital COVID‐19 referral center. We report no...
Gespeichert in:
| Veröffentlicht in: | Journal of medical virology 2022-01, Vol.94 (1), p.404-406 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 406 |
|---|---|
| container_issue | 1 |
| container_start_page | 404 |
| container_title | Journal of medical virology |
| container_volume | 94 |
| creator | Akinosoglou, Karolina Delastic, Anne‐Lise Dimakopoulou, Vasilina Marangos, Markos Gogos, Charalambos |
| description | The presence of a complex immune dysregulation syndrome has been established in COVID‐19 patients. We aimed to assess Th1/Th2 response in COVID‐19 patients and its association with disease severity by performing a prospective cohort study in a tertiary hospital COVID‐19 referral center. We report no difference between Th1/Th2 responses between patients with severe and mild disease, except for levels of interleukin‐6 (IL‐6) and IL‐10. Future larger studies should examine lung‐specific versus systemic inflammatory responses, as well as, diverse immunotypes driving poor clinical outcomes. |
| doi_str_mv | 10.1002/jmv.27313 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8662005</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2566261690</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4203-24c5424a58911be4c61a6d0481f90b3aa0b6af6b49548aa8ddb0ae594105a5193</originalsourceid><addsrcrecordid>eNp1kc1u1DAUhS1ERYfCgjewxAYW6dzrv8YskKqhlFZF3QwVO8tJHMajJE7tzKDZ9RH6jDxJXaZCAonVvdL9ztG5OoS8QThGADZf99tjdsKRPyMzBK0KDSf4nMwAhSqUQnlIXqa0BoBSM_aCHHIhFCCTM_L9rHO9G6ZEQ0uXK5wvV4xGl8YwJEft0NDGJ2fzntzWRT_tqB_o4vrm4tOvu3vUdLSTf9R_oKc0rUKcsnrM4xU5aG2X3OuneUS-fT5bLr4UV9fnF4vTq6IWDHjBRC0FE1aWGrFyolZoVQOixFZDxa2FStlWVUJLUVpbNk0F1kktEKSVqPkR-bj3HTdV75o6Z4m2M2P0vY07E6w3f18GvzI_wtaUSjEAmQ3ePRnEcLtxaTK9T7XrOju4sEmGyQwqVBoy-vYfdB02ccjvZUorrjlKnqn3e6qOIaXo2j9hEMxjXyb3ZX73ldn5nv3pO7f7P2guv97sFQ8FaZTY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2596393153</pqid></control><display><type>article</type><title>Elements of Th1/Th2 response and disease severity in COVID‐19 patients: A short report</title><source>Wiley Journals</source><creator>Akinosoglou, Karolina ; Delastic, Anne‐Lise ; Dimakopoulou, Vasilina ; Marangos, Markos ; Gogos, Charalambos</creator><creatorcontrib>Akinosoglou, Karolina ; Delastic, Anne‐Lise ; Dimakopoulou, Vasilina ; Marangos, Markos ; Gogos, Charalambos</creatorcontrib><description>The presence of a complex immune dysregulation syndrome has been established in COVID‐19 patients. We aimed to assess Th1/Th2 response in COVID‐19 patients and its association with disease severity by performing a prospective cohort study in a tertiary hospital COVID‐19 referral center. We report no difference between Th1/Th2 responses between patients with severe and mild disease, except for levels of interleukin‐6 (IL‐6) and IL‐10. Future larger studies should examine lung‐specific versus systemic inflammatory responses, as well as, diverse immunotypes driving poor clinical outcomes.</description><identifier>ISSN: 0146-6615</identifier><identifier>EISSN: 1096-9071</identifier><identifier>DOI: 10.1002/jmv.27313</identifier><identifier>PMID: 34460125</identifier><language>eng</language><publisher>London: Wiley Subscription Services, Inc</publisher><subject>COVID-19 ; Inflammation ; Interleukins ; Lymphocytes T ; Patients ; SARS‐CoV‐2 ; Short Communication ; Th1/Th2 response ; Virology</subject><ispartof>Journal of medical virology, 2022-01, Vol.94 (1), p.404-406</ispartof><rights>2021 Wiley Periodicals LLC</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4203-24c5424a58911be4c61a6d0481f90b3aa0b6af6b49548aa8ddb0ae594105a5193</citedby><cites>FETCH-LOGICAL-c4203-24c5424a58911be4c61a6d0481f90b3aa0b6af6b49548aa8ddb0ae594105a5193</cites><orcidid>0000-0001-7465-0784 ; 0000-0002-4289-9494</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjmv.27313$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjmv.27313$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,780,784,885,1417,27924,27925,45574,45575</link.rule.ids></links><search><creatorcontrib>Akinosoglou, Karolina</creatorcontrib><creatorcontrib>Delastic, Anne‐Lise</creatorcontrib><creatorcontrib>Dimakopoulou, Vasilina</creatorcontrib><creatorcontrib>Marangos, Markos</creatorcontrib><creatorcontrib>Gogos, Charalambos</creatorcontrib><title>Elements of Th1/Th2 response and disease severity in COVID‐19 patients: A short report</title><title>Journal of medical virology</title><description>The presence of a complex immune dysregulation syndrome has been established in COVID‐19 patients. We aimed to assess Th1/Th2 response in COVID‐19 patients and its association with disease severity by performing a prospective cohort study in a tertiary hospital COVID‐19 referral center. We report no difference between Th1/Th2 responses between patients with severe and mild disease, except for levels of interleukin‐6 (IL‐6) and IL‐10. Future larger studies should examine lung‐specific versus systemic inflammatory responses, as well as, diverse immunotypes driving poor clinical outcomes.</description><subject>COVID-19</subject><subject>Inflammation</subject><subject>Interleukins</subject><subject>Lymphocytes T</subject><subject>Patients</subject><subject>SARS‐CoV‐2</subject><subject>Short Communication</subject><subject>Th1/Th2 response</subject><subject>Virology</subject><issn>0146-6615</issn><issn>1096-9071</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp1kc1u1DAUhS1ERYfCgjewxAYW6dzrv8YskKqhlFZF3QwVO8tJHMajJE7tzKDZ9RH6jDxJXaZCAonVvdL9ztG5OoS8QThGADZf99tjdsKRPyMzBK0KDSf4nMwAhSqUQnlIXqa0BoBSM_aCHHIhFCCTM_L9rHO9G6ZEQ0uXK5wvV4xGl8YwJEft0NDGJ2fzntzWRT_tqB_o4vrm4tOvu3vUdLSTf9R_oKc0rUKcsnrM4xU5aG2X3OuneUS-fT5bLr4UV9fnF4vTq6IWDHjBRC0FE1aWGrFyolZoVQOixFZDxa2FStlWVUJLUVpbNk0F1kktEKSVqPkR-bj3HTdV75o6Z4m2M2P0vY07E6w3f18GvzI_wtaUSjEAmQ3ePRnEcLtxaTK9T7XrOju4sEmGyQwqVBoy-vYfdB02ccjvZUorrjlKnqn3e6qOIaXo2j9hEMxjXyb3ZX73ldn5nv3pO7f7P2guv97sFQ8FaZTY</recordid><startdate>202201</startdate><enddate>202201</enddate><creator>Akinosoglou, Karolina</creator><creator>Delastic, Anne‐Lise</creator><creator>Dimakopoulou, Vasilina</creator><creator>Marangos, Markos</creator><creator>Gogos, Charalambos</creator><general>Wiley Subscription Services, Inc</general><general>John Wiley and Sons Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7TK</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-7465-0784</orcidid><orcidid>https://orcid.org/0000-0002-4289-9494</orcidid></search><sort><creationdate>202201</creationdate><title>Elements of Th1/Th2 response and disease severity in COVID‐19 patients: A short report</title><author>Akinosoglou, Karolina ; Delastic, Anne‐Lise ; Dimakopoulou, Vasilina ; Marangos, Markos ; Gogos, Charalambos</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4203-24c5424a58911be4c61a6d0481f90b3aa0b6af6b49548aa8ddb0ae594105a5193</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>COVID-19</topic><topic>Inflammation</topic><topic>Interleukins</topic><topic>Lymphocytes T</topic><topic>Patients</topic><topic>SARS‐CoV‐2</topic><topic>Short Communication</topic><topic>Th1/Th2 response</topic><topic>Virology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Akinosoglou, Karolina</creatorcontrib><creatorcontrib>Delastic, Anne‐Lise</creatorcontrib><creatorcontrib>Dimakopoulou, Vasilina</creatorcontrib><creatorcontrib>Marangos, Markos</creatorcontrib><creatorcontrib>Gogos, Charalambos</creatorcontrib><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of medical virology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Akinosoglou, Karolina</au><au>Delastic, Anne‐Lise</au><au>Dimakopoulou, Vasilina</au><au>Marangos, Markos</au><au>Gogos, Charalambos</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Elements of Th1/Th2 response and disease severity in COVID‐19 patients: A short report</atitle><jtitle>Journal of medical virology</jtitle><date>2022-01</date><risdate>2022</risdate><volume>94</volume><issue>1</issue><spage>404</spage><epage>406</epage><pages>404-406</pages><issn>0146-6615</issn><eissn>1096-9071</eissn><abstract>The presence of a complex immune dysregulation syndrome has been established in COVID‐19 patients. We aimed to assess Th1/Th2 response in COVID‐19 patients and its association with disease severity by performing a prospective cohort study in a tertiary hospital COVID‐19 referral center. We report no difference between Th1/Th2 responses between patients with severe and mild disease, except for levels of interleukin‐6 (IL‐6) and IL‐10. Future larger studies should examine lung‐specific versus systemic inflammatory responses, as well as, diverse immunotypes driving poor clinical outcomes.</abstract><cop>London</cop><pub>Wiley Subscription Services, Inc</pub><pmid>34460125</pmid><doi>10.1002/jmv.27313</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0001-7465-0784</orcidid><orcidid>https://orcid.org/0000-0002-4289-9494</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0146-6615 |
| ispartof | Journal of medical virology, 2022-01, Vol.94 (1), p.404-406 |
| issn | 0146-6615 1096-9071 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8662005 |
| source | Wiley Journals |
| subjects | COVID-19 Inflammation Interleukins Lymphocytes T Patients SARS‐CoV‐2 Short Communication Th1/Th2 response Virology |
| title | Elements of Th1/Th2 response and disease severity in COVID‐19 patients: A short report |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T04%3A46%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Elements%20of%20Th1/Th2%20response%20and%20disease%20severity%20in%20COVID%E2%80%9019%20patients:%20A%20short%20report&rft.jtitle=Journal%20of%20medical%20virology&rft.au=Akinosoglou,%20Karolina&rft.date=2022-01&rft.volume=94&rft.issue=1&rft.spage=404&rft.epage=406&rft.pages=404-406&rft.issn=0146-6615&rft.eissn=1096-9071&rft_id=info:doi/10.1002/jmv.27313&rft_dat=%3Cproquest_pubme%3E2566261690%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2596393153&rft_id=info:pmid/34460125&rfr_iscdi=true |